Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational Modeling Unveils the Impact of Tissue Growth and Vascular Remodeling on the Distribution of Interstitial Chemical Species.

Annals of biomedical engineering·2026
Same author

Mechanistic multiphysics modeling reveals how blood pulsation drives CSF flow, pressure, and brain deformation under physiological and injection conditions.

Fluids and barriers of the CNS·2026
Same author

From molecule to absorption: a multiscale framework for subcutaneous biologic delivery.

Advanced drug delivery reviews·2026
Same author

Effect of electric charge on biotherapeutic transport, binding and absorption: A computational study.

International journal of pharmaceutics·2026
Same author

A computational framework for predicting leakage in subcutaneous injections.

International journal of pharmaceutics·2025
Same author

Mathematical modeling and simulation of tumor-induced angiogenesis in retinal hemangioblastoma.

PLoS computational biology·2025

Related Experiment Video

Updated: Dec 24, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.0K

How heterogeneity drives tumour growth: a computational study.

Hector Gomez1,2,3

  • 1School of Mechanical Engineering, Purdue University, West Lafayette, IN, USA.

Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|April 14, 2020
PubMed
Summary

Tumour heterogeneity, the presence of diverse cell types within a cancerous tumor, significantly accelerates cancer growth. This computational model reveals how even mild variations in cell proliferation rates drive faster tumor expansion.

Keywords:
Fisher–Kolmogorovcomputational methodstumour heterogeneity

More Related Videos

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.6K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Related Experiment Videos

Last Updated: Dec 24, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.0K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.6K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Area of Science:

  • Computational biology
  • Cancer research
  • Mathematical modeling

Background:

  • Cancerous tumors typically arise from a single cell but evolve into heterogeneous cell populations.
  • Tumor heterogeneity is a universal feature of cancer, yet its origins and implications are not fully understood.
  • While often linked to poor prognosis, understanding tumor heterogeneity could enable personalized cancer diagnosis and therapy.

Purpose of the Study:

  • To computationally model tumor heterogeneity and its impact on tumor growth.
  • To investigate the competitive dynamics between different cell subpopulations within a tumor.
  • To elucidate the mechanistic link between heterogeneity and accelerated tumor growth.

Main Methods:

  • Development of a computational model simulating cell subpopulations competing for space.
  • Analysis of tumor growth dynamics under varying degrees of heterogeneity in cell proliferation rates.

Main Results:

  • The model indicates that aggressive tumor subpopulations can become more aggressive when co-existing with non-aggressive ones.
  • Mild heterogeneity in proliferation rates between cell subpopulations leads to significantly faster overall tumor growth compared to homogeneous tumors.
  • The study provides a mechanistic explanation for how heterogeneity drives tumor growth.

Conclusions:

  • Computational modeling offers a valuable approach to studying tumor heterogeneity.
  • Tumor heterogeneity, even mild, can be a key driver of accelerated tumor growth.
  • The findings may inform new hypotheses for experimental testing in cancer research.